Publications by authors named "Syeda Kainat Zehra Kazmi"

• Page 1 of 1

Iwilfin (eflornithine) approved by the FDA as the first and only oral maintenance therapy for high-risk neuroblastoma in adult and pediatric patients: Narrative review.

Ayesha Shakeel Aniqa Baloch Versha Kumari Syeda Kainat Zehra Kazmi Kanza Aftab

Medicine (Baltimore)

November 2024

Article Synopsis

View Article and Find Full Text PDF

Privacy Policy Site Map

Contact Us

© LitMetric 2024. All rights reserved.